AMR

Approved antibiotics and those under clinical development are insufficient to arrest AMR: Rex Clements, Centrient Pharmaceuticals

Read more

Cabinet approves MoU between ICMR and GARDP Foundation on AMR research and innovation

Read more

White paper calls for action on AMR

Read more

Cipla Therapeutics and SIGA Technologies enter into strategic partnership

Read more

Blueprint for progress

Read more

Effective effluent management: Key to tackle AMR

Read more

GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections

Read more

UK-India experts’ drive to stop antibiotic waste creating more ‘superbugs’

Read more

Childhood vaccines reduce antibiotic consumption in low and middle income countries

Read more

A wake-up call for One Health

Read more